Adverse Event Reporting
| VAERS ID | 2545152 |
|---|---|
| Gender | Male |
| Age | 68 |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | GJ2675 |
| Number of vaccinations | 5 |
| Vaccinated | 2022-12-01 |
| Onset | 2022-12-03 |
| Condition | Permanent Disability Recovered |
Symptoms
- Feeling abnormal
- Hypoaesthesia
- Myalgia
- Joint range of motion decreased
Current Illness
Preexisting Conditions
Medical History/Concurrent Conditions: Hypertension
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Write-up
feeling strange on the shoulder; The arm became unable to lift; numbness in hand; Myalgia; This is a spontaneous report received from a contactable reporter(s) (Physician).
Regulatory number: v2210003358.
A 68-year-old male patient received BNT162b2, BNT162b2 omi ba.
4-5 (COMIRNATY RTU FOR BA.
4-5), on 01Dec2022 at 02:00 as dose 5 (booster), single (Lot number: GJ2675, Expiration Date: 31Jul2023) at the age of 68 years intramuscular, in left arm for covid-19 immunisation.
The patient's relevant medical history included: "Hypertension" (unspecified if ongoing).
The patient's concomitant medications were not reported.
Vaccination history included: Covid-19 vaccine (Primary Immunization Completed, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 3, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 4, MANUFACTURER UNKNOWN), for COVID-19 immunisation.
The following information was reported: MYALGIA (non-serious) with onset 03Dec2022, outcome "recovered"; JOINT RANGE OF MOTION DECREASED (disability) with onset 03Dec2022, outcome "unknown", described as "The arm became unable to lift"; FEELING ABNORMAL (disability) with onset 03Dec2022, outcome "unknown", described as "feeling strange on the shoulder"; HYPOAESTHESIA (disability) with onset 03Dec2022, outcome "unknown", described as "numbness in hand".
Therapeutic measures were taken as a result of feeling abnormal, joint range of motion decreased, hypoaesthesia, myalgia.
Clinical course: The patient had no allergies to medications, food, or other products.
The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.
Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19.
Since the vaccination, it was unknown if the patient had been tested for COVID-19.
On 03Dec2022 (2 days after the vaccination), the patient experienced adverse events as follows: 2 days later, feeling strange on the shoulder occurred, which persisted for 2 weeks.
The arm became unable to lift.
Myalgia disappeared within around 2 days.
There was also numbness in hand.
The event resulted in disability or permanent damages.
The outcome of the events was unknown (as reported) with treatment including oral administration of vitamin B12, vitamin E.